Skip to Content

The five-year-old Pacific trial on stage lll Non-small-cell cancer still reveals new findings.

In this MEDtalk the Chief Scientific Officer from Sarah Cannon research institute, David Speigel gives you the latest results from the five-year-old trial, that show a significant reduction in survival rates for patients.

David R. Spigel

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Back to top